Biden and congressional Democrats crafted wide-ranging drug pricing provisions, including allowing Medicare to negotiate for the first time, in the Build Back Better Act. But that bill and its parts now appear dead, largely thanks to Sen. Joe Manchin (D-WV), who balked at some of the non-drug-related provisions.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,